Hemostasis using Gelatin-based Hemostatic-Matrix in Pediatric Tonsillectomy and/or Adenoidectomy
Abdulmohsen E Al-Terki*
Chairman of ENT College for Post-Graduate Training, Kuwait Institute of Medical Specialization (KIMS), General Secretary of the Kuwait ENT Society, Head of Unit and Consultant, ENT Department, Zain and Al-Sabah Hospitals, State of Kuwait, Kuwait
- Corresponding Author:
- Abdulmohsen E Al-Terki
PO Box: 3764, Mishref, 40188
Hiwally, State of Kuwait, Kuwait
Tel: 9659900 0436
Fax: 965 2531 6565
E-mail: [email protected]
Received date: November 23, 2014; Accepted date: December 08, 2014; Published date: December 18, 2014
Citation: Al-Terki AE (2015) Hemostasis using Gelatin-based Hemostatic-Matrix in Pediatric Tonsillectomy and/or Adenoidectomy. Otolaryngol (Sunnyvale) 5:181. doi:10.4172/2161-119X.1000181
Copyright: © 2015 Al-Terki AE. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: The aim of this study was to evaluate the applicability and safety of gelatin-based hemostatic matrix in children undergoing tonsillectomy and/or adenoidectomy.
Study design: This study was prospective, single-arm case series study conducted in a three tertiary care centers in Kuwait, from August to December 2011.
Methods: Seventy five children were enrolled (48 male and 27 female) with average age of 3.80 ± 2.14 years. Sixty six underwent tonsillectomy and adenoidectomy, seven tonsillectomy alone and two adenoidectomy alone; by same surgeon and same procedures. Surgiflo was applied for 214 surfaces with an average of 2.85 surfaces/patient via an applicator tip connected to the 12 ml syringe pre- filled with Surgiflo mixed with 5 ml normal saline.
Results: Hemostasis was achieved in all 75 patients within 5 minutes of product application without stitches, ties or cautery. The mean blood loss was 11.63 ± 4.40 ml, with a 95% CI (10.61-12.64). The mean duration of operation was 20.57 ± 4.22 minutes, with a 95% CI of (19.60-21.55). The mean time to return to normal diet after operation was 2.11 ± 0.80 days, with a 95% CI of (1.92-2.29). The incidence of adverse events and postoperative complications including hemorrhage in the follow up period was 0%.
Conclusion: Gelatin-based hemostatic matrix (Surgiflo) alone was successful in achieving hemostasis and safe in all patients who underwent tonsillectomy and/or adenoidectomy. Further RCTs are needed to compare the application of Surgiflo in tonsillectomy and/or adenoidectomy to other conventional methods.